Neville Teo

Dr. Neville Teo

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2022 in BMJ
Verified
Journal Article
Open access
PDF file
BTBenjamin Kye Jyn Tan
Benjamin Kye Jyn Tan
RHRuobing Han
Ruobing Han
JZJoseph J Zhao
Joseph J Zhao
NTNicole Kye Wen Tan
Nicole Kye Wen Tan
EQEmrick Sen Hui Quah
Emrick Sen Hui Quah
STSong Tar Toh
Song Tar Toh
Objective: To clarify in patients with covid-19 the recovery rate of smell and taste, proportion with persistent dysfunction of smell and taste, and prognostic factors associated with recovery of smell and taste. Design: Systematic review and meta-analysis. Data sources: PubMed, Embase, Scopus, Cochrane Library, and medRxiv from inception to 3 October 2021. Review methods: Two blinded reviewers selected observational studies of adults (≥18 years) with covid-19 related dysfunction of smell or taste. Descriptive prognosis studies with time-to-event curves and prognostic association studies of any prognostic factor were included. Data extraction and synthesis: Two reviewers extracted data, evaluated study bias using QUIPS, and appraised evidence quality using GRADE, following PRISMA and MOOSE reporting guidelines. Using iterative numerical algorithms, time-to-event individual patient data (IPD) were reconstructed and pooled to retrieve distribution-free summary survival curves, with recovery rates reported at 30 day intervals for participants who remained alive. To estimate the proportion with persistent smell and taste dysfunction, cure fractions from Weibull non-mixture cure models of plateaued survival curves were logit transformed and pooled in a two stage meta-analysis. Conventional aggregate data meta-analysis was performed to explore unadjusted associations of prognostic factors with recovery. Main outcome measures: The primary outcomes were the proportions of patients remaining with smell or taste dysfunction. Secondary outcomes were the odds ratios of prognostic variables associated with recovery of smell and taste. Results: 18 studies (3699 patients) from 4180 records were included in reconstructed IPD meta-analyses. Risk of bias was low to moderate; conclusions remained unaltered after exclusion of four high risk studies. Evidence quality was moderate to high. Based on parametric cure modelling, persistent self-reported smell and taste dysfunction could develop in an estimated 5.6% (95% confidence interval 2.7% to 11.0%, I 2 =70%, τ 2 =0.756, 95% prediction interval 0.7% to 33.5%) and 4.4% (1.2% to 14.6%, I 2 =67%, τ 2 =0.684, 95% prediction interval 0.0% to 49.0%) of patients, respectively. Sensitivity analyses suggest these could be underestimates. At 30, 60, 90, and 180 days, respectively, 74.1% (95% confidence interval 64.0% to 81.3%), 85.8% (77.6% to 90.9%), 90.0% (83.3% to 94.0%), and 95.7% (89.5% to 98.3%) of patients recovered their sense of smell (I 2 =0.0-77.2%, τ 2 =0.006-0.050) and 78.8% (70.5% to 84.7%), 87.7% (82.0% to 91.6%), 90.3% (83.5% to 94.3%), and 98.0% (92.2% to 95.5%) recovered their sense of taste (range of I 2 =0.0-72.1%, τ 2 =0.000-0.015). Women were less likely to recover their sense of smell (odds ratio 0.52, 95% confidence interval 0.37 to 0.72, seven studies, I 2 =20%, τ 2 =0.0224) and taste (0.31, 0.13 to 0.72, seven studies, I 2 =78%, τ 2 =0.5121) than men, and patients with greater initial severity of dysfunction (0.48, 0.31 to 0.73, five studies, I 2 =10%, τ 2 <0.001) or nasal congestion (0.42, 0.18 to 0.97, three studies, I 2 =0%, τ 2 <0.001) were less likely to recover their sense of smell. Conclusions: A substantial proportion of patients with covid-19 might develop long lasting change in their sense of smell or taste. This could contribute to the growing burden of long covid. Systematic review registration: PROSPERO CRD42021283922.

7 April 2022 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
NPNatalie Yan-Lin Pang
Natalie Yan-Lin Pang
HSHarris Jun Jie Muhammad Danial Song
Harris Jun Jie Muhammad Danial Song
BTBenjamin Kye Jyn Tan
Benjamin Kye Jyn Tan
JTJun Xiang Tan
Jun Xiang Tan
ACAshley Si Ru Chen
Ashley Si Ru Chen
NTNeville Teo
Neville Teo
Population-based studies of olfactory impairment (OI) indicate an overall prevalence ranging from 19% to 24%,1-3 with a prevalence exceeding 50% for individuals aged 65 to 80 years, and reaching 80% among those older than 80 years.4 Olfactory impairment is also associated with multiple comorbidities: neurogenerative,5-7 cardiovascular,8 nutritional,9 and immune disorders.10,11 Although OI is common, it frequently goes unnoticed compared with other senses, such as hearing or vision.3,12 Because olfaction is used for a variety of purposes and is a critical component of human physiology,13 its impairment may result in appetite suppression and malnutrition,9 decreased safety14 owing to increased risk of hazardous events (eg, cooking-related incidents, ingestion of spoiled food, and accidental gas poisoning), and overall lower quality of life.15

22 March 2022 in The Laryngoscope
Verified
Journal Article
Open access
CTClaire Jing‐Wen Tan
Claire Jing‐Wen Tan
BTBenjamin Kye Jyn Tan
Benjamin Kye Jyn Tan
XTXin Yan Tan
Xin Yan Tan
HLHui Ting Liu
Hui Ting Liu
CTChong Boon Teo
Chong Boon Teo
NTNeville Teo
Neville Teo
Objective: Olfactory dysfunction (OD) is a common presenting symptom of COVID‐19 infection. Radiological imaging of the olfactory structures in patients with COVID‐19 and OD can potentially shed light on its pathogenesis, and guide clinicians in prognostication and intervention.Methods: PubMed, Embase, Cochrane, SCOPUS were searched from inception to August 1, 2021. Three reviewers selected observational studies, case series, and case reports reporting radiological changes in the olfactory structures, detected on magnetic resonance imaging, computed tomography, or other imaging modalities, in patients aged ≥18 years with COVID‐19 infection and OD, following preferred reporting items for systematic reviews and meta‐analyses guidelines and a PROSPERO‐registered protocol (CRD42021275211). We described the proportion of radiological outcomes, and used random‐effects meta‐analyses to pool the prevalence of olfactory cleft opacification, olfactory bulb signal abnormalities, and olfactory mucosa abnormalities in patients with and without COVID‐19‐associated OD.Results: We included 7 case–control studies (N = 353), 11 case series (N = 154), and 12 case reports (N = 12). The pooled prevalence of olfactory cleft opacification in patients with COVID‐19 infection and OD (63%, 95% CI = 0.38–0.82) was significantly higher than that in controls (4%, 95% CI = 0.01–0.13). Conversely, similar proportions of cases and controls demonstrated olfactory bulb signal abnormalities (88% and 94%) and olfactory mucosa abnormalities (2% and 0%). Descriptive analysis found that 55.6% and 43.5% of patients with COVID‐19 infection and OD had morphological abnormalities of the olfactory bulb and olfactory nerve, respectively, while 60.0% had abnormal olfactory bulb volumes.Conclusion: Our findings implicate a conductive mechanism of OD, localized to the olfactory cleft, in approximately half of the affected COVID‐19 patients. Laryngoscope, 132:1260–1274, 2022

19 March 2017 in World Journal of Otorhinolaryngology - Head and Neck Surgery
Verified
Journal Article
Open access
NTNeville Teo
Neville Teo
JMJess C. Mace
Jess C. Mace
TSTimothy L. Smith
Timothy L. Smith
PHPeter H. Hwang
Peter H. Hwang
Objective: To evaluate improvements in otologic symptoms after endoscopic sinus surgery (ESS) in patients with chronic rhinosinusitis (CRS), and identify differences in symptoms, if any, between CRS patients with (CRSwNP) and without (CRSsNP) nasal polyposis. Material and methods This is a prospective multi-center observational cohort study. Adults with medically recalcitrant CRS who elected ESS were enrolled in a prospective, multi-center, observational cohort study between March, 2011 and October, 2014. Preoperative evaluation of subjects included assessment of clinical characteristics, measures of disease severity, and quality of life evaluation using the 22-item SinoNasal Outcome Test (SNOT-22). Postoperative improvement in otologic symptoms (ear fullness, dizziness, ear pain) scores were evaluated and compared between CRSwNP and CRSsNP subgroups. Results: Three hundred and ninety-five study patients completed both preoperative and postoperative evaluations, with an average follow-up of 13.9 months after ESS. The prevalence of patients reporting at least one otologic symptom preoperatively (87%) significantly decreased after ESS (63%, P < 0.001). Significant postoperative improvement across all otologic scores was also reported (P < 0.001). Relative mean improvement in otologic symptom severity was similar for both CRSwNP and CRSsNP, except patients with CRSwNP reported significantly greater postoperative improvement in ear fullness compared to CRSsNP (54% vs. 41%, P = 0.039). A total of 61%, 44%, and 43% of patients reported experiencing improvement in “ear fullness”, “dizziness” and “ear pain”, respectively. Conclusion: Sinus surgery significantly improves otologic symptoms associated with CRS. CRSwNP patients reported slightly greater relief of ear fullness than CRSsNP patients following ESS.

10 July 2025 in International Forum of Allergy & Rhinology
Verified
Journal Article
Open access
BYBrian Sheng Yep Yeo
Brian Sheng Yep Yeo
HSHarris Jun Jie Muhammad Danial Song
Harris Jun Jie Muhammad Danial Song
BTBenjamin Kye Jyn Tan
Benjamin Kye Jyn Tan
ASAdithya Suresh
Adithya Suresh
OHOwen Tsung Wen Ho
Owen Tsung Wen Ho
NTNeville Teo
Neville Teo
Background: Olfactory impairment (OI) is associated with poor ageing outcomes. While cross‐sectional studies found a high prevalence of OI among patients with neurodegenerative diseases, the temporal relationship remains unclear. This meta‐analysis aims to synthesise the longitudinal association of OI with cognitive decline (CD). Methods: PubMed, Embase and Web of Science were searched through August 9, 2024 for longitudinal studies reporting on self‐reported and objectively measured OI in adults, in association with CD, measured using validated methods. The outcome of interest was incident CD. Independent authors extracted data, assessed for bias and graded the strength of evidence. A mixed‐effects meta‐analysis with subgroup, sensitivity and bias analyses was conducted. The population‐attributable fraction (PAF) of OI‐associated CD was calculated. Results: This study included 48 articles and 37,783 participants. OI patients had a 2.06‐fold greater risk of any CD (risk ratio [RR] = 2.06; 95% CI = 1.87‒2.26, I 2 = 0%), compared to individuals with normal olfaction. Patients with severe OI had a higher risk of any CD (RR = 2.60; 95% CI = 2.12‒3.20, I 2 = 0%) than patients with moderate OI (RR = 1.51; 95% CI = 1.23‒1.85, I 2 = 0%). The risk of any CD increased by 18% per 10% decrease in olfactory score (RR = 1.18; 95% CI = 1.14‒1.22, I 2 = 24%) and by 15% per point decrement on the Sniffin’ Sticks Odor Identification Test (RR = 1.15; 95% CI = 1.11‒1.18, I 2 = 0%). These results remained robust to supplementary analyses. The PAF of OI‐associated incident CD was 18%. Conclusion: OI may increase the risk of CD, with poorer olfaction linked to greater risks. OI should be assessed as a potential cognitive screening tool, and cognitive screening should be considered in patients with long‐standing OI.

14 October 2022 in Rhinology Online
Verified
Journal Article
Closed access
SXS. Xu
S. Xu
MVM. Vallei
M. Vallei
JGJ. Hwang Siok Gek
J. Hwang Siok Gek
CCC. Tze Choong
C. Tze Choong
NTNeville Teo
Neville Teo
Background: Chronic rhinosinusitis is a heterogenous disease with variation in the endotypes of nasal polyps, with type 2 inflammation being more prevalent in Caucasian populations whereas Chinese populations are more heterogenous. We aim to describe the variation in endotypes for patients with chronic rhinosinusitis with nasal polyposis in our unique multiracial population. Methodology: Demographic, clinical and structured histopathological data of 66 patients who underwent sinus surgery for nasal polyposis were evaluated retrospectively. Results: 54.6% had eosinophilic disease, and 45.4% had non-eosinophilic disease with no significant demographic differences between the 2 populations. There were significantly higher peripheral eosinophil levels in patients with eosinophil-predominant inflammation on tissue histology (mean absolute eosinophil count 0.59 ± 0.18 x 109) compared with non-eosinophilic disease (mean absolute eosinophil count 0.24 ± 0.11 x 109). Structured histopathological reporting revealed that patients with eosinophilic disease had higher degree of inflammation and eosinophil aggregates. Conclusions: Our population is shown to have a slight preponderance toward eosinophilic disease, however the Chinese majority tended to have non-eosinophilic disease. Serum eosinophilia and the presence of asthma seems to correlate well with tissue eosinophilia, which can potentially be utilised as markers of type 2 inflammatory disease.